Italian study checks how well newborn screening detects rare hormone disorder
NCT ID NCT06728748
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study looked at newborn screening for congenital adrenal hyperplasia (CAH) in Italy. Researchers reviewed medical records of 29 infants diagnosed with classic CAH between 2006 and 2019 to see how accurate the screening was. The goal was to measure the screening's sensitivity and positive predictive value, and to describe the babies' health at diagnosis.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help improve newborn screening programs for congenital adrenal hyperplasia, leading to earlier diagnosis and better outcomes.
What could go wrong
This is a small, retrospective study with only 29 participants, so results may not apply to larger or different populations. It does not test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONGENITAL ADRENAL HYPERPLASIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Azienda Ospedaliera Città della Salute e della Scienza di Torino
Torino, Torino, 10123, Italy
-
Azienda Ospedaliera Universitaria Integrata Verona:
Verona, Verona, 37126, Italy
-
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Bologna, 40138, Italy
-
IRCCS Ospedale San Raffaele
Milan, Milano, 20132, Italy